Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

Impact of season of diagnosis on mortality among breast cancer survivors


1 National Cancer Institute, Baublio 3B, LT 08406 Vilnius, Lithuania
2 Scientific Research Centre, National Cancer Institute, Santariskiu g. 1, LT-08660 Vilnius, Lithuania
3 Radiotherapy and Drug Therapy Centre, National Cancer Institute, Santariskiu g. 1, LT-08660 Vilnius, Lithuania
4 Department of Thoracic Surgery and Oncology, National Cancer Institute, Santariskiu g. 1, LT-08660 Vilnius, Lithuania

Correspondence Address:
Irena Kuzmickiene,
Laboratory of Cancer Epidemiology, National Cancer Institute, Baublio 3B, LT-08406 Vilnius
Lithuania
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Introduction: There is mounting evidence that the time of breast cancer diagnosis and the start of treatment can improve survival rates. The aim of this study was to test the relationship between the season of breast cancer diagnosis and the survival of women patients receiving standard surgery treatment with radiotherapy. Materials and Methods: The nonmetastatic breast cancer patients (n = 991) were followed from the date of diagnosis until death. Cox proportional hazards models were used to calculate multivariate hazard ratios (HRs) for all-cause mortality. HRs and 95% confidence intervals (CIs) were estimated in models adjusted for clinicopathologic and treatment factors. Results: After adjusting for independent prognostic variables, we found that patients diagnosed in summer and autumn had a 40% reduced risk for 0-3-year mortality when compared to those diagnosed in spring. Among women aged <50 years, HRs comparing autumn with spring diagnosis categories were 0.53 (95% CI: 0.31-0.91) for 0-5-years and 0.68 (95% CI: 0.46-0.89) for 5-10-years after diagnosis. Diagnosis in autumn was associated with improving survival in younger patients treated with adjuvant chemotherapy (HR = 0.61, 95% CI: 0.39-0.96, P = 0.003). Conclusions: The diagnosis in summer and autumn was associated with a better overall prognosis. The effect of season of diagnosis on survival rate was most pronounced in the young age patients receiving chemotherapy.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Kuzmickiene I
    -  Atkocius V
    -  Aleknavicius E
    -  Ostapenko V
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed143    
    PDF Downloaded28    

Recommend this journal